NanoBio

HR Notices From June 14

The latest personnel and boardroom moves by Michigan’s technology-focused companies and institutions

WWJ Newsradio 950–06/14/2011

HR Notices From May 25

The latest personnel and boardroom announcements from Michigan’s technology-focused institutions and companies

WWJ Newsradio 950–05/25/2011

nanobio

NanoBio, GSK Start Phase 3 Studies Of Cold Sore Treatment

Ann Arbor-based NanoBio Corp. Wednesday announced the initiation of two Phase 3 trials evaluating its drug candidate NB-001 as a topical treatment for cold sores, a step forward in its over-the-counter drug licensing agreement with GlaxoSmithKline Consumer Healthcare

WWJ Newsradio 950–05/11/2011

nanobio

NanoBio, UM Develop Nasal Vaccine To Prevent Urinary Infections

NanoBio Corp. today announced a licensing agreement with the University of Michigan that provides NanoBio with rights to an antigen that has been shown to prevent urinary tract infections following intranasal vaccination

WWJ Newsradio 950–04/20/2011

research

NanoBio Gets $6M Gates Grant For Nasal RSV Vaccine

Ann Arbor-based NanoBio Corporation announced Tuesday that it has received a $6 million grant from the Bill & Melinda Gates Foundation to support development of an intranasal vaccine for Respiratory Syncytial Virus.

11/30/2010

NanoBio Gets Patent On Cold Sore Product

Ann Arbor-based NanoBio Corp. said Tuesday that it had been awarded its seventh United States patent covering its novel nanoemulsion technology. The new claims encompass methods of treating Herpes Simplex I infections, including herpes labialis, […]

08/03/2010

previous

Follow

Get every new post delivered to your Inbox.

Join 2,463 other followers